Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marie-José Grange"'
Autor:
Gil Tchernia, Marie-José Grange, Narla Mohandas, Martin Sorette, Thérèse Cynober, Lydie Da Costa
Publikováno v:
Blood. 98:2894-2899
Spherocytic red cells with reduced membrane surface area are a feature of hereditary spherocytosis (HS) and some forms of autoimmune hemolytic anemia (AIHA). It is generally assumed that membrane loss in spherocytic red cells occurs during their sojo
Autor:
Marie-José Grange, Catherine Pasquier, Emmanuelle Rollet-Labelle, Claude Marquetty, Carole Elbim, Marie-Anne Gougerot-Pocidalo
Publikováno v:
Free Radical Biology and Medicine. 24:563-572
We investigated reactive oxygen species (ROS) involvement in polymorphonuclear neutrophilic leukocyte (neutrophil) apoptosis triggering. Neutrophils were incubated with xanthine oxidase (XO), which produces superoxide anion (O2.-) and hydrogen peroxi
Autor:
Marie Echard, Jean-Didier Rain, Yves Najean, Françoise Lejeune, Alain Goguel, Dresch C, Marie-José Grange
Publikováno v:
Leukemia & Lymphoma. 22:111-119
An analysis of the risk of progression towards leukemia, carcinoma and myelofibrosis was performed in 93 patients treated by 32P alone (PVSG protocols) since 1970-1979, 395 patients over the age of 65 years treated by 32P with or without maintenance
Autor:
Sylvia Bellucci, Bruno Cassinat, Kamel Ghomari, Pierre Fenaux, Sylvie Chevret, Jean-Jacques Kiladjian, Christine Chomienne, Philippe Rousselot, Marie-José Grange, Lina Abdelkader-Aljassem, William Vainchenker, Nathalie Parquet, Jean-Luc Dutel, Jean-François Bernard, Murielle Roussel, Gerald Massonnet, M L Menot, Nathalie Cambier, Pascal Turlure, Yasmina Chait, Jean-Didier Rain
Publikováno v:
Blood. 108(6)
V617F JAK2 mutation is a reliable molecular marker of polycythemia vera (PV), potentially useful to monitor the effect of treatments in this disease. In a phase 2 study of pegylated (peg) IFN-alpha-2a in PV, we performed prospective sequential quanti
Publikováno v:
American journal of hematology. 74(1)
We report a case of severe priapism occurring in a patient with unstable hemoglobin, hemoglobin Köln, and underline several factors that may have contributed to this complication: abnormal plasticity of red cells, splenectomy, and cytomegalovirus in
Publikováno v:
Annales de medecine interne. 153(5)
First described in 1948, Bernard-Soulier syndrome is an uncommon hereditary thrombopathy characterized by abnormal expression of the GPIb-IX-V complex which inhibits platelet migration to the site of endothelial trauma. Our case illustrates the patho
Autor:
Sylvie Chevret, Stéphane Cheze, Bertrand Godeau, François Bassompierre, Bruno Varet, Olivier Fain, Eric Legouffe, Philippe Bierling, Marie-José Grange, Cyrille Hulin, François Lefrère, Jean-Marc Zini
Publikováno v:
Lancet (London, England). 359(9300)
Summary Background Treatment of adults with autoimmune thrombocytopenic purpura (AITP) is based more on individual experience than on results of controlled studies. We compared intravenous immunoglobulin with high-dose methylprednisolone in untreated
Autor:
Nathalie Cambier, Pascal Turlure, Murielle Roussel, Bernard Grandchamp, Bruno Cassinat, Jean-Didier Rain, Sylvia Bellucci, Pierre Fenaux, Jean-Jacques Kiladjian, Christine Chomienne, Marie-José Grange
Publikováno v:
Blood. 108:670-670
Background: IFNα can control erythrocytosis in 75% of PV while avoiding leukemogenicity of myelosuppressive drugs, but 20–25% of patients stop therapy due to side effects. Peg IFNα −2b, allowing weekly use, showed similar efficacy but no better
Autor:
Christine Chomienne, Nathalie Cambier, Pascal Turlure, Murielle Roussel, Sylvia Bellucci, Jean-Didier Rain, Jean-Jacques Kiladjian, Pierre Fenaux, Marie-José Grange, Bruno Cassinat
Publikováno v:
Blood. 106:4940-4940
Background: Interferon-α (IFN) can control erythrocytosis in about 75% of PV patients and may even induce cytogenetic remission while avoiding the leukemogenic potential of myelosuppressive drugs. However, 20–25% of patients discontinue therapy du
Publikováno v:
American Journal of Hematology. 53:149-149